HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vestibulocochlear Nerve Diseases

Pathological processes of the VESTIBULOCOCHLEAR NERVE, including the branches of COCHLEAR NERVE and VESTIBULAR NERVE. Common examples are VESTIBULAR NEURITIS, cochlear neuritis, and ACOUSTIC NEUROMA. Clinical signs are varying degree of HEARING LOSS; VERTIGO; and TINNITUS.
Also Known As:
Acoustic Nerve Disorders; Cochlear Nerve Disorders; Cochlear Neuritis; Cranial Nerve VIII Disorders; Eighth Cranial Nerve Diseases; Vestibular Nerve Disorders; Acoustic Nerve Disease; Acoustic Nerve Disorder; Cochlear Nerve Disease; Cochlear Nerve Disorder; Cochlear Neuritides; Neuritides, Cochlear; Neuritis, Cochlear; Vestibular Nerve Disease; Vestibular Nerve Disorder; Vestibulocochlear Nerve Disease; Acoustic Nerve Diseases; Cochlear Nerve Diseases; Cranial Nerve VIII Diseases; Vestibular Nerve Diseases
Networked: 23 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Related Diseases

1. Vestibular Neuronitis (Vestibular Neuritis)
2. Hearing Loss (Hearing Impairment)
3. Herpes Zoster Oticus (Geniculate Neuralgia)
4. Silicosis
5. Otitis Media

Experts

1. Li, Xin: 1 article (02/2022)
2. Sun, Xiaohua: 1 article (02/2022)
3. Yang, Dong: 1 article (02/2022)
4. Chang, Bin: 1 article (08/2018)
5. Fukao, Eri: 1 article (08/2018)
6. Honma, Yutaka: 1 article (08/2018)
7. Inose, Yuri: 1 article (08/2018)
8. Kamio, Satoshi: 1 article (08/2018)
9. Kitahara, Nobuo: 1 article (08/2018)
10. Morii, Daiichi: 1 article (08/2018)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Vestibulocochlear Nerve Diseases:
1. Therapeutic UsesIBA
2. mecobalamin (methylcobalamin)IBA
3. Galantamine (Galanthamine)FDA LinkGeneric
4. pyrogenalIBA
5. Phosphorus CompoundsIBA
6. Trinitrotoluene (TNT)IBA
7. Neostigmine (Neostigmine Bromide)IBA
8. GadoliniumIBA
9. Cinnarizine (Cinna)IBA
10. Ceftriaxone (Ceftriaxon)FDA LinkGeneric

Therapies and Procedures

1. Therapeutics
2. Phonophoresis
3. Reflexotherapy
4. Secondary Prevention